Justine Jacobi

6PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersReaction engineering (excl. nuclear reactions)Molecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.

|Jul 01, 2026
Nuclear-specific reductive carboxylation of alpha-ketoglutarate fuels histone acetylation to induce chromatin accessibility and gene activation.

|Nov 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.

Justine J Jacobi, Kristine M Wadosky, Neha Jaiswal

|Oct 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi

|Apr 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles.

Candice L Bizzaro, Camila A Bach, Ricardo A Santos

|Sep 27, 2022
JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy.

Spencer R Rosario, Justine J Jacobi, Mark D Long

Pageof 1

Frequent Collaborators

4 joint publications

Mark D Long

3 joint publications

David W Goodrich

2 joint publications

Dominic J Smiraglia

2 joint publications

Alessandro Fatatis